Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Biovail and Technilab Pharma sign marketing agreement

Oct. 23, 1997

German launch for Roche's mibefradil

Oct. 22, 1997

Atlantic's sulfated cyclodextrins effective in preclinical models of restenosis

Oct. 21, 1997

P&G agrees to outlicense antiarrhythmic drug

Oct. 21, 1997

CPC-111 reduces pain of sickle cell crises in phase II

Oct. 21, 1997

Andrx's Diltia XT approved and launched in U.S.

Oct. 20, 1997

Effects of 5-HT, TxA2 and their antagonists on restenosis

Oct. 20, 1997

Clinical results reported for 546C88 in septic shock

Oct. 20, 1997

Draflazine: a potential cardioprotectant with a novel mechanism of action

Oct. 17, 1997

Alpha1-antichymotrypsin analogues described in patent literature

Oct. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026